Lancaster Colony (LANC)
(Delayed Data from NSDQ)
$169.94 USD
+1.08 (0.64%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $170.00 +0.06 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$169.94 USD
+1.08 (0.64%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $170.00 +0.06 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Zacks News
Lamb Weston's (LW) Latest Expansion Effort to Accelerate Growth
by Zacks Equity Research
Lamb Weston (LW) to buy the remaining equity interests in its European joint venture with Meijer Frozen Foods B.V. by the second half of fiscal 2023.
Capacity Expansion Aids Hormel Foods (HRL), High Costs Ail
by Zacks Equity Research
Hormel Foods (HRL) is on track with strategic investments to boost capacity. However, rising cost inflation is a concern.
Altria (MO)-Philip Morris Strike a Deal for IQOS Transition
by Zacks Equity Research
Altria (MO) to receive $2.7 billion from Philip Morris (PM) in exchange for the exclusive right to sell IQOS heated tobacco products in the United States.
Philip Morris (PM) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2022 results reflect increased earnings and revenues, with favorable pricing variance remaining an upside.
Buy These 4 Low-Beta Stocks to Combat Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Scorpio Tankers Inc. (STNG), AMN Healthcare (AMN), Ardmore (ASC) and Lancaster (LANC) are poised to gain.
Is Lancaster Colony (LANC) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Lancaster Colony (LANC) and PepsiCo (PEP) have performed compared to their sector so far this year.
Mondelez (MDLZ) Snacking Category Aids Amid Cost Pressure
by Zacks Equity Research
Mondelez (MDLZ) is seeing input cost inflation, especially for energy and transportation, among others. However, strong pricing efforts and a focus on the snacking category bode well.
Beyond Meat (BYND) to Cut Workforce, Slashes 2022 Revenue View
by Zacks Equity Research
Beyond Meat (BYND) lowers 2022 revenue guidance amid rising inflation and increased competition. Also, the company unveils plans to cut the workforce.
Lamb Weston (LW) Stock Up More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) is benefiting from effective pricing actions. The company's efforts to boost production capacity and fuel long-term growth are noteworthy.
Helen of Troy (HELE) Looks Troubled: Stock Down 25% in 3 Months
by Zacks Equity Research
Helen of Troy (HELE) has been battling escalated cost concerns and softness in its Beauty segment. Management lowered its fiscal 2023 guidance on the last earnings call.
TreeHouse Foods (THS) Looks Promising: Pricing a Major Driver
by Zacks Equity Research
TreeHouse Foods (THS) has been gaining from the favorable demand for private label products and efficient pricing initiatives.
The J.M. Smucker (SJM) Gains on Solid Pricing, Coffee Business
by Zacks Equity Research
The J.M. Smucker (SJM) has been benefiting from strength in the coffee business, a focus on core strategies, a revival in the Away from Home division and pricing amid cost inflation and supply-chain woes.
Nu Skin's (NUS) Focus on Nu Vision 2025 & Product Launches Aids
by Zacks Equity Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.
McCormick (MKC) Q3 Earnings Beat Estimates, Sales Increase Y/Y
by Zacks Equity Research
McCormick's (MKC) third-quarter fiscal 2022 results reflect higher sales on strength in both segments. However, earnings decline year over year.
Conagra (CAG) Q1 Earnings Top Estimates, Sales Increase Y/Y
by Zacks Equity Research
Conagra Brands' (CAG) first-quarter fiscal 2023 results reflect increased earnings and sales. In spite of favorable pricing, volume declines persist.
Helen of Troy (HELE) Cuts FY23 View Despite Q2 Earnings Beat
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2023 results reflect lower earnings. Management lowers sales and earnings guidance for fiscal 2023.
Lamb Weston (LW) Q1 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Lamb Weston's (LW) first-quarter fiscal 2023 results reflect increased earnings and sales due to the robust pricing undertaken to battle the significant cost inflation.
Post Holdings (POST) Benefits From Buyouts, Foodservice Unit
by Zacks Equity Research
Post Holdings (POST) has been gaining from acquisitions and a recovery in the Foodservice business. These, along with pricing, bode well for the company amid cost inflation.
Pilgrim's Pride (PPC) is Poised on Capacity Expansion Efforts
by Zacks Equity Research
Pilgrim's Pride (PPC) benefits from its focus on strategic growth initiatives, like capacity expansions and a customer-centric approach.
United Natural (UNFI) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
United Natural's (UNFI) fourth-quarter fiscal 2022 results reflect higher earnings and sales, with all channels witnessing sales growth. Management issues an encouraging view for fiscal 2023.
United Natural Foods' (UNFI) Deal With Symbotic to Aid Growth
by Zacks Equity Research
United Natural Foods (UNFI) inks a deal with Symbotic to use the latter's robotics and software automation across five of its distribution centers.
The Estee Lauder Companies (EL) & BALMAIN to Launch a Beauty Line
by Zacks Equity Research
The Estee Lauder Companies (EL) signs a license agreement with BALMAIN to introduce BALMAIN BEAUTY. The collaboration is likely to launch in fall 2024.
The Zacks Analyst Blog Highlights PepsiCo, Lancaster Colony, Chesapeake Utilities, NextEra Energy and Otter Tail
by Zacks Equity Research
PepsiCo, Lancaster Colony, Chesapeake Utilities, NextEra Energy and Otter Tail are part of the Zacks Analyst Blog.
Kimberly-Clark's (KMB) Growth Pillars & Cost Cutting Efforts Aid
by Zacks Equity Research
Kimberly-Clark (KMB) is focused on its three key strategic growth pillars. The company is undertaking relevant cost-cutting initiatives amid the inflationary environment.
Play Safe as Market Volatility Climbs on Rate Hike: 5 Picks
by Tirthankar Chakraborty
Amid Fed-induced sell-off, investing in risk-adjusted stocks like PepsiCo (PEP), Lancaster Colony (LANC), Chesapeake Utilities (CPK), NextEra Energy (NEE) and Otter Tail (OTTR) seems prudent at the moment.